MONDAY, July 7 (HealthDay News) -- Children with attention-deficit hyperactivity disorder (ADHD) are at a 50 percent higher risk for being overweight if they are not taking medication for the condition, a new study finds.
On the other hand, youngsters who were medicated for ADHD had a raised risk of being ... Read More
Tag: David W. Goodman MD
27
May2008
TUESDAY, May 27 (HealthDay News) -- Adults with attention deficit hyperactivity disorder (ADHD) miss, on average, more than three weeks a year in workplace productivity, according to a new global reckoning of the problem.
Altogether, between 3 percent and 4 percent of adults worldwide have ADHD, according to survey data from ... Read More
May 27, 2008David W. Goodman, MD
30
Apr2008
Kollins S, Goodman D, 2008. Improving Functional Outcomes in Adolescent and Adult ADHD Efficacy and Safety of Pharmacologic Therapies. Supplement to Psychiatric Times. Reporter. April 2008 Special Edition
April 30, 2008David W. Goodman, MD
27
Apr2008
NEW YORK -- April 24, 2008 -- The US Food and Drug Administration (FDA) has approved lisdexamfetamine dimesylate (Vyvanse) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. Introduced in July 2007 for the treatment of ADHD in children aged 6 to 12 years, lisdexamfetamine is the first and only ... Read More
April 27, 2008David W. Goodman, MD
28
Feb2008
Goodman, D.W. “Critical Issues in the Management of Depression” American Journal of Managed Care, February, 2000; 6:2 (suppl), 26-30.
February 28, 2008David W. Goodman, MD
05
Feb2008
A literature search found five empirical studies or psychological treatment for adults with ADHD, out of 1,419 articles on ADHD in adults. Practice guidelines to date all recommend multimodal intervention, given that a significant number of patients cannot tolerate, do not respond to, or fail to rearch optimal outcomes with ... Read More
February 5, 2008David W. Goodman, MD
30
Sep2007
David W. Goodman, M.D. The Consequences of Attention-Deficit Hyperactivity Disorder in Adults. Journal of Psychiatric Practice. Vol. 13, No. 5. September 2007
September 30, 2007David W. Goodman, MD
31
Aug2007
David W. Goodman, M.D. Lisdexamfetamine Dimesylate-The First Prodrug Stimulant. Psychiatry – August 2007
August 31, 2007David W. Goodman, MD
28
Jun2007
Goodman DW, Surman CB. Pharmacotherapy of Adult ADHD. Medscape. June 28. 2007. CME accredited
June 28, 2007David W. Goodman, MD
27
Jun2007
Goodman DW. A Rational Approach to Diagnosis and Treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in Adolescents and Adults. Expert Interview. Medscape, June 7, 2007. CME accredited
June 27, 2007David W. Goodman, MD